Head Department of Internal Medicine @Radboudumc. Professor fighting venous thromboembolism. Pregnancy, thrombosis, thrombophilia. Council @ISTH. Feminist.
Nijmegen, Nederland
Joined March 2017
- Tweets8.7K
- Following414
- Followers5.2K
- Likes13.4K
Pinned Tweet
My mission is to generate high-quality evidence about #LMWH in #pregnancy. 2022 is the year of completion of #Highlow and #ALIFE2. Collaboration is key. Thanks to all who contribute! @INVENT_VTE @isth
Saskia Middeldorp retweeted
De nieuwste aflevering staat online en is getiteld voorzitters. Hierin een gesprek met @MiddeldorpS als beoogd voorzitter der NIV en @LiffertVogt als nieuwe voorzitter van de NfN en daarnaast de vaste rubrieken.
Nu in je favoriete podcast app!
Saskia Middeldorp retweeted
Your voice matters! Let us know which topics and emerging therapies in thrombosis and hemostasis you're excited to explore in 2025. Take a moment to share your insights and help shape our educational offerings!
📩 Participate in the survey now: survey.alchemer.com/s3/81272…
Very well deserved! 🏆 - team science!!
Very proud of the MulderLab @radboudumc team and recognition from the department of internal medicine. Thanks to our chief @MiddeldorpS 🙏🏼 and my agent😜
Saskia Middeldorp retweeted
So proud of the @isth community as we approach our goal for the Claire McLintock Memorial Award. Thanks to everyone who has contributed so far - we're almost there! Donate here: isth.org/claireaward #ISTHGives #ISTH
Belangrijk opiniestuk over wetenschap en dierproeven, wat ook ik ondertekende. Natuurlijk zo min mogelijk, maar soms is het de enige manier voorwaarts. nrc.nl/nieuws/2024/12/11/die…
Saskia Middeldorp retweeted
"Resistance is futile? Not on Bluesky! 🚀 Tired of X's algorithmic chaos? We're building a smarter, kinder social space. Join the migration and rediscover social media's potential! 💡" bit.ly/3BrXKgE
Saskia Middeldorp retweeted
Great to be at #ASH24 with amazing women at the #WomenInHematology networking reception.
Ladies and gentlemen, get your ASHes over here #ASH24 grand Hyatt Coronado ballroom for a lovely Women in Hematology event @bsamuelson_md @TamaraDunnMD and many more exceptional people
Saskia Middeldorp retweeted
"Clinical practice guideline or guidance documents should be undertaken with the busy practicing clinician – not the clinician-researcher – as the primary audience. What use are clinical practice guidelines and guidance documents if they are ignored by clinicians? Accordingly, such documents should be concise, practical, and with actionable advice."
🏥 Read about this exciting path forward porposed by the @isth Guidelines and Guidance Committee
@fniainle @MiddeldorpS @connors_md @Sa_Eichinger_MD @acweyand
jthjournal.org/article/S1538…
Saskia Middeldorp retweeted
Great speakers and great talks updating hormones and thrombosis at #ASH24! @MiddeldorpS @Clotmaster
Extended-dose DOAC vs full-dose DOAC #Renove RCT #ASH24 Late breaking abstract. Officially, reduced dose was not non-inferior, but recurrent #VTE rates were low and there is a substantial reduction in major and non-major bleeding. Congrats to @FCouturaud & @INNOVTE1
Ladies and gentlemen, get your ASHes over here #ASH24 grand Hyatt Coronado ballroom for a lovely Women in Hematology event @bsamuelson_md @TamaraDunnMD and many more exceptional people
Saskia Middeldorp retweeted
Hi colleagues! For my updates on #VTE and #anticoagulation from #ASH24 - please come and join us on the other side 🦋. I have the same handle: @middeldorps.bsky.social.
Saying hi to our amazing @isth team #ASH24, and look what they had in store fore me! The must-have coagulation clock designed by @JHMorrissey.
Join us in Washington DC in June 2025. This will be the PREMIER event in #thrombosis and #haemostasis of 2025!!
Saskia Middeldorp retweeted
Dr. @LeaderAvi provided a great review on initiation of anticoagulation in patients with brain metastatic disease. No difference between LMWH and DOACs and management needs to be tailored based on risk of ICH (risk factors and MRI findings)
#ASH24
The RCT Renove will answer this question during the late-breaking abstracts session on Tuesday #ASH24
Interesting study presented at #ASH24 by @StopTheClot #CERT member @JordanKSchaefer looking at treatment vs prophylactic #DOAC for #VTE management. @umichmedicine
Saskia Middeldorp retweeted
Interesting study presented at #ASH24 by @StopTheClot #CERT member @JordanKSchaefer looking at treatment vs prophylactic #DOAC for #VTE management. @umichmedicine
Large multi-national cohort study of pts with MPN and splanchnic vein thrombosis shows high risk of recurrent thrombosis and bleeding in first year - more patients and analyses to come! #ASH24 very proud of @MandyNLauw and colleagues!
